Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bo Ren

Showing results (471-480 of 480) with videos related to

Pageof 48
Sort By:
You have reached the last page of results.This site can display upto 480 results.
BMC Complementary Medicine and Therapies|February 3, 2023
Terminally ill patients' and their relatives' experiences and behaviors regarding complementary and alternative medicine utilization in hospice palliative inpatient care units: a cross-sectional, multicenter surveyYu-Jia Lin, Hsiao-Ting Chang, Ming-Hwai Lin, et al.
Bioorganic Chemistry|April 8, 2026
Discovery of a potent and orally available SOS1 inhibitor with antitumor efficacy in KRAS-mutant colorectal cancersXingchen Liu, Yuzhou Xiao, Lingfeng Tang, et al.
Journal of Experimental & Clinical Cancer Research : CR|October 2, 2024
CALB2 drives pancreatic cancer metastasis through inflammatory reprogramming of the tumor microenvironmentJinxin Tao, Yani Gu, Zeyu Zhang, et al.
Nature Communications|February 20, 2020
Gut microbiota mediates intermittent-fasting alleviation of diabetes-induced cognitive impairmentZhigang Liu, Xiaoshuang Dai, Hongbo Zhang, et al.
Integrative Medicine Research|November 9, 2020
Professionals' experiences and attitudes toward use of Traditional Chinese Medicine in hospice palliative inpatient care units: A multicenter survey in TaiwanYu-Jia Lin, Hsiao-Ting Chang, Ming-Hwai Lin, et al.
Neoplasia (New York, N.Y.)|July 12, 2020
Pamiparib is a potent and selective PARP inhibitor with unique potential for the treatment of brain tumorYao Xiong, Yin Guo, Ye Liu, et al.
Annals of Translational Medicine|August 15, 2022
A better overall survival (OS) for total (ipsilateral) retroperitoneal lipectomy than standard complete resection in patients with retroperitoneal liposarcoma: a comparative multi-institutional studyCheng-Li Miao, Ling-Ling Zhang, William W Tseng, et al.
Journal of Medicinal Chemistry|June 5, 2026
Discovery of Highly Potent and Selective SOS1 Inhibitors for the Treatment of KRAS-Driven Colorectal CancerXingchen Liu, Yuzhou Xiao, Yanmei Zhou, et al.
Journal of Neurosurgery|February 20, 2026
Pallidus internus versus subthalamic nucleus deep brain stimulation for Meige syndrome: a randomized, controlled, double-blind multicenter trialYang Wu, Hai-Bo Ren, Bo-Tao Xiong, et al.
Journal of Medicinal Chemistry|December 2, 2020
Discovery of Pamiparib (BGB-290), a Potent and Selective Poly (ADP-ribose) Polymerase (PARP) Inhibitor in Clinical DevelopmentHexiang Wang, Bo Ren, Ye Liu, et al.
Pageof 48

Showing results (471-480 of 480) with videos related to

Sort By:
Pageof 48
You have reached the last page of results.This site can display upto 480 results.
BMC Complementary Medicine and Therapies|February 3, 2023
Terminally ill patients' and their relatives' experiences and behaviors regarding complementary and alternative medicine utilization in hospice palliative inpatient care units: a cross-sectional, multicenter surveyYu-Jia Lin, Hsiao-Ting Chang, Ming-Hwai Lin, et al.
Bioorganic Chemistry|April 8, 2026
Discovery of a potent and orally available SOS1 inhibitor with antitumor efficacy in KRAS-mutant colorectal cancersXingchen Liu, Yuzhou Xiao, Lingfeng Tang, et al.
Journal of Experimental & Clinical Cancer Research : CR|October 2, 2024
CALB2 drives pancreatic cancer metastasis through inflammatory reprogramming of the tumor microenvironmentJinxin Tao, Yani Gu, Zeyu Zhang, et al.
Nature Communications|February 20, 2020
Gut microbiota mediates intermittent-fasting alleviation of diabetes-induced cognitive impairmentZhigang Liu, Xiaoshuang Dai, Hongbo Zhang, et al.
Integrative Medicine Research|November 9, 2020
Professionals' experiences and attitudes toward use of Traditional Chinese Medicine in hospice palliative inpatient care units: A multicenter survey in TaiwanYu-Jia Lin, Hsiao-Ting Chang, Ming-Hwai Lin, et al.
Neoplasia (New York, N.Y.)|July 12, 2020
Pamiparib is a potent and selective PARP inhibitor with unique potential for the treatment of brain tumorYao Xiong, Yin Guo, Ye Liu, et al.
Annals of Translational Medicine|August 15, 2022
A better overall survival (OS) for total (ipsilateral) retroperitoneal lipectomy than standard complete resection in patients with retroperitoneal liposarcoma: a comparative multi-institutional studyCheng-Li Miao, Ling-Ling Zhang, William W Tseng, et al.
Journal of Medicinal Chemistry|June 5, 2026
Discovery of Highly Potent and Selective SOS1 Inhibitors for the Treatment of KRAS-Driven Colorectal CancerXingchen Liu, Yuzhou Xiao, Yanmei Zhou, et al.
Journal of Neurosurgery|February 20, 2026
Pallidus internus versus subthalamic nucleus deep brain stimulation for Meige syndrome: a randomized, controlled, double-blind multicenter trialYang Wu, Hai-Bo Ren, Bo-Tao Xiong, et al.
Journal of Medicinal Chemistry|December 2, 2020
Discovery of Pamiparib (BGB-290), a Potent and Selective Poly (ADP-ribose) Polymerase (PARP) Inhibitor in Clinical DevelopmentHexiang Wang, Bo Ren, Ye Liu, et al.
Pageof 48